フィルフィニッシュ医薬品受託製造市場：製品別、エンドユーザー別-2025-2030年の世界予測

フィルフィニッシュ医薬品受託製造市場の2023年の市場規模は104億7,000万米ドルで、2024年には113億8,000万米ドルに達すると予測され、CAGR 9.28%で成長し、2030年には194億9,000万米ドルに達すると予測されています。

フィルフィニッシュ医薬品受託製造は、医薬品がバイアルやシリンジなどの容器に充填され、流通のために包装される、医薬品製造プロセスの最終段階のアウトソーシングを指します。このサービスは、リソースを大量に必要とし、規制を遵守するという性質上、非常に重要であり、中小企業や能力の限られた組織では社内で管理することが困難な場合があります。充填仕上げサービスの最終用途は製薬会社、バイオテクノロジー企業、ヘルスケア機関など多岐にわたる。同市場の主な成長要因としては、生物製剤やバイオシミラーの生産増加、注射剤需要の拡大、個別化医療の進展、高度なドラッグデリバリーシステムを後押しする慢性疾患の有病率の上昇などが挙げられます。充填仕上げ作業の自動化やパッケージング材料の革新など、最近の技術進歩は、メーカーが効率を高め、汚染リスクを低減する潜在的な機会を提供しています。これを活用するため、企業は複雑な製剤に対応できる能力の拡大と、持続可能な包装ソリューションへの投資に注力すべきです。しかし、運用コストの高さ、規制要件の厳しさ、専門施設の必要性といった課題は、市場の成長を妨げる可能性があります。さらに、COVID-19パンデミックによる混乱は、世界のサプライチェーンの課題による懸念として残っています。技術革新が必要な分野としては、環境にやさしい製造プロセスの開発、充填・仕上げ作業におけるデジタル追跡技術の統合、精度と安全性を高めるための品質保証の強化などが挙げられます。市場力学は、激しい競争と急速な技術進歩を特徴とするダイナミックな市場であり、研究開発への継続的な投資と生産能力の拡大が成長の持続に不可欠です。バイオテクノロジー・イノベーターとのコラボレーションを受け入れ、適応可能な製造ソリューションを導入することは、将来的な市場リーダーシップにとって極めて重要です。

市場力学：急速に進化するフィルフィニッシュ医薬品受託製造市場の主要市場インサイトを公開

フィルフィニッシュ医薬品受託製造市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 生物学的製剤の承認件数の増加
  • フィル・フィニッシュ製造工程の技術進歩およびアウトソーシングの増加
  • 多品種指向型施設の利用拡大
• 市場抑制要因
  • サービスコストの高騰と複雑な規制状況
• 市場機会
  • 充填仕上げ工程の効率性、正確性、安全性を高めるための自動化およびロボット工学の採用の増加
  • 個別化医療に対応する柔軟な製造システムへのシフトの高まり
• 市場の課題
  • 関連製造施設の無菌性維持に関する技術的問題

ポーターのファイブフォース：フィルフィニッシュ医薬品受託製造市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：フィルフィニッシュ医薬品受託製造市場における外部からの影響の把握

外部マクロ環境要因は、フィルフィニッシュ医薬品受託製造市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析フィルフィニッシュ医薬品受託製造市場における競合情勢の把握

フィルフィニッシュ医薬品受託製造市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスフィルフィニッシュ医薬品受託製造市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、フィルフィニッシュ医薬品受託製造市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨フィルフィニッシュ医薬品受託製造市場における成功への道筋を描く

フィルフィニッシュ医薬品受託製造市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大の可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品上市、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 生物学的製剤の承認件数の増加
    • 充填・仕上げ製造プロセスとアウトソーシングにおける技術進歩の増加
    • 多品種対応型施設の利用拡大
  • 抑制要因
    • サービスの高コストと複雑な規制状況
  • 機会
    • 充填・仕上げ工程における効率、精度、安全性を高めるために自動化とロボットの導入を拡大
    • 個別化医療に対応する柔軟な製造システムへの移行が増加
  • 課題
    • 関連製造施設における無菌性の維持に関する技術的問題
• 市場セグメンテーション分析
  • 製品：充填仕上げ作業用計装機器の進歩
  • エンドユーザー：製薬会社およびバイオ医薬品会社における多様な用途
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 フィルフィニッシュ医薬品受託製造市場：製品別

• 消耗品
  • アンプル
  • ボトル
  • カートリッジ
  • IVs
  • プレフィルドシリンジ
  • バイアル
• 機器
  • マシンタイプ
  • システム
    • 統合システム
    • スタンドアロンシステム

第7章 フィルフィニッシュ医薬品受託製造市場：エンドユーザー別

• 学術調査機関
• 契約製造組織
• 製薬・バイオ医薬品企業
• 研究開発研究所

第8章 南北アメリカのフィルフィニッシュ医薬品受託製造市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のフィルフィニッシュ医薬品受託製造市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのフィルフィニッシュ医薬品受託製造市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • ステヴァナートグループがEZ充填キットとラボ充填・仕上げサービスを開始
  • Cytovance BiologicsとAlcamiが提携し、無菌充填・仕上げオペレーションを最適化
  • サムスンバイオロジクスとクルマパートナーズは、クルマのポートフォリオ企業向けの生物製剤の開発と製造に関する戦略的提携を発表
• 戦略分析と提言

企業一覧

• AbbVie Inc.
• Ajinomoto Bio-Pharma Services
• Argonaut Manufacturing Services
• Baxter International, Inc.
• Boehringer Ingelheim International GmbH
• Catalent Inc.
• Chemtech International, Inc.
• Eurofins Scientific SE
• Federal Equipment Company
• Fresenius Kabi Contract Manufacturing
• GBI Biomanufacturing
• Gerresheimer AG
• Grand River Aseptic Manufacturing
• Groninger & Co. GmbH
• Jubilant HollisterStier CMO
• MabPlex International Co. Ltd.
• Novartis AG
• OPTIMA Packaging Group GmbH
• Pfizer Inc.
• Piramal Pharma Solutions
• Recipharm AB
• Societal CDMO
• Syngene International Ltd.
• Syntegon Pharma Technology
• Vetter Pharma International

LIST OF FIGURES

• FIGURE 1. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET RESEARCH PROCESS
• FIGURE 2. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET DYNAMICS
• TABLE 7. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY AMPOULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CARTRIDGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY IVS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY VIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MACHINE TYPE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STANDALONE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY RESEARCH & DEVELOPMENT LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 44. CANADA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. CANADA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 46. CANADA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 47. CANADA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 48. CANADA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 71. CHINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. CHINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 73. CHINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 74. CHINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 75. CHINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 76. INDIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. INDIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 78. INDIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 79. INDIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 80. INDIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 162. ITALY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 163. ITALY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 164. ITALY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 165. ITALY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 166. ITALY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 182. POLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 183. POLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 184. POLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 185. POLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 186. POLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 187. QATAR FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 188. QATAR FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 189. QATAR FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 190. QATAR FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 191. QATAR FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 237. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 238. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023

The Fill-finish Pharmaceutical Contract Manufacturing Market was valued at USD 10.47 billion in 2023, expected to reach USD 11.38 billion in 2024, and is projected to grow at a CAGR of 9.28%, to USD 19.49 billion by 2030.

Fill-finish pharmaceutical contract manufacturing refers to the outsourcing of the final steps in the pharmaceutical production process, where drug products are filled into vials, syringes or other containers, and packaged for distribution. This service is critical due to its resource-intensive and regulatory-compliant nature, which smaller companies or organizations with limited capacity may struggle to manage in-house. The application scope of fill-finish services is broad, covering biologics, vaccines, and other injectables, with end-use domains spanning across pharmaceutical companies, biotechnology firms, and healthcare institutions. Key growth influences in this market include the increasing production of biologics and biosimilars, growing demand for injectables, advancement in personalized medicine, and the rising prevalence of chronic diseases that push for sophisticated drug delivery systems. Recent technological advancements, such as automation in fill-finish operations, and innovation in packaging materials, present potential opportunities for manufacturers to enhance efficiency and reduce contamination risks. To capitalize, companies should focus on expanding capabilities to accommodate complex formulations and invest in sustainable packaging solutions. However, challenges such as high operational costs, stringent regulatory requirements, and the need for specialized facilities could hamper market growth. Further, the COVID-19 pandemic-induced disruptions remain a concern due to the global supply chain challenges. Areas ripe for innovation include development of eco-friendly manufacturing processes, integration of digital tracking technologies during fill-finish operations, and enhancements in quality assurance to augment precision and safety. The fill-finish pharmaceutical contract manufacturing market is dynamic, characterized by intense competition and rapid technological advancement, making continual investment in R&D and capacity expansion vital for sustaining growth. Embracing collaborations with biotech innovators and implementing adaptable manufacturing solutions are crucial for future market leadership.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Fill-finish Pharmaceutical Contract Manufacturing Market

The Fill-finish Pharmaceutical Contract Manufacturing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising number of biologic drugs approval
  • Increasing technological advancements in fill-finish manufacturing processes and outsourcing
  • Growing usage of multi-product-use-oriented facilities
• Market Restraints
  • High cost of services and complex regulatory landscape
• Market Opportunities
  • Increasing adoption of automation and robotics to enhance efficiency, accuracy, and safety in fill-finish processes
  • Rising shift towards flexible manufacturing systems catering to personalized medicine
• Market Challenges
  • Technical issues related to maintaining sterility in associated manufacturing facility

Porter's Five Forces: A Strategic Tool for Navigating the Fill-finish Pharmaceutical Contract Manufacturing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Fill-finish Pharmaceutical Contract Manufacturing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Fill-finish Pharmaceutical Contract Manufacturing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Fill-finish Pharmaceutical Contract Manufacturing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Fill-finish Pharmaceutical Contract Manufacturing Market

A detailed market share analysis in the Fill-finish Pharmaceutical Contract Manufacturing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Fill-finish Pharmaceutical Contract Manufacturing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Fill-finish Pharmaceutical Contract Manufacturing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Fill-finish Pharmaceutical Contract Manufacturing Market

A strategic analysis of the Fill-finish Pharmaceutical Contract Manufacturing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Fill-finish Pharmaceutical Contract Manufacturing Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Ajinomoto Bio-Pharma Services, Argonaut Manufacturing Services, Baxter International, Inc., Boehringer Ingelheim International GmbH, Catalent Inc., Chemtech International, Inc., Eurofins Scientific SE, Federal Equipment Company, Fresenius Kabi Contract Manufacturing, GBI Biomanufacturing, Gerresheimer AG, Grand River Aseptic Manufacturing, Groninger & Co. GmbH, Jubilant HollisterStier CMO, MabPlex International Co. Ltd., Novartis AG, OPTIMA Packaging Group GmbH, Pfizer Inc., Piramal Pharma Solutions, Recipharm AB, Societal CDMO, Syngene International Ltd., Syntegon Pharma Technology, and Vetter Pharma International.

Market Segmentation & Coverage

This research report categorizes the Fill-finish Pharmaceutical Contract Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Consumables and Instruments. The Consumables is further studied across Ampoules, Bottles, Cartridges, IVs, Prefilled Syringes, and Vials. The Instruments is further studied across Machine Type and Systems. The Systems is further studied across Integrated Systems and Standalone Systems.
• Based on End-users, market is studied across Academic Research Institutions, Contract Manufacturing Organizations, Pharmaceutical & Biopharmaceutical Companies, and Research & Development laboratories.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising number of biologic drugs approval
    • 5.1.1.2. Increasing technological advancements in fill-finish manufacturing processes and outsourcing
    • 5.1.1.3. Growing usage of multi-product-use-oriented facilities
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of services and complex regulatory landscape
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing adoption of automation and robotics to enhance efficiency, accuracy, and safety in fill-finish processes
    • 5.1.3.2. Rising shift towards flexible manufacturing systems catering to personalized medicine
  • 5.1.4. Challenges
    • 5.1.4.1. Technical issues related to maintaining sterility in associated manufacturing facility
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Advancements in instrumentations for fill-finish operations
  • 5.2.2. End-users: Diverse applications in pharmaceutical & biopharmaceutical companies
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Fill-finish Pharmaceutical Contract Manufacturing Market, by Product

• 6.1. Introduction
• 6.2. Consumables
  • 6.2.1. Ampoules
  • 6.2.2. Bottles
  • 6.2.3. Cartridges
  • 6.2.4. IVs
  • 6.2.5. Prefilled Syringes
  • 6.2.6. Vials
• 6.3. Instruments
  • 6.3.1. Machine Type
  • 6.3.2. Systems
    • 6.3.2.1. Integrated Systems
    • 6.3.2.2. Standalone Systems

7. Fill-finish Pharmaceutical Contract Manufacturing Market, by End-users

• 7.1. Introduction
• 7.2. Academic Research Institutions
• 7.3. Contract Manufacturing Organizations
• 7.4. Pharmaceutical & Biopharmaceutical Companies
• 7.5. Research & Development laboratories

8. Americas Fill-finish Pharmaceutical Contract Manufacturing Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Fill-finish Pharmaceutical Contract Manufacturing Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Fill-finish Pharmaceutical Contract Manufacturing Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. Stevanato Group Launches EZ-fill Kit and Laboratory Fill and Finish Service
  • 11.3.2. Cytovance Biologics, Alcami Partner to Optimize Sterile Fill-Finish Ops
  • 11.3.3. Samsung Biologics and Kurma Partners announce strategic partnership for development and manufacturing of biologics for Kurma's portfolio companies
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Ajinomoto Bio-Pharma Services
• 3. Argonaut Manufacturing Services
• 4. Baxter International, Inc.
• 5. Boehringer Ingelheim International GmbH
• 6. Catalent Inc.
• 7. Chemtech International, Inc.
• 8. Eurofins Scientific SE
• 9. Federal Equipment Company
• 10. Fresenius Kabi Contract Manufacturing
• 11. GBI Biomanufacturing
• 12. Gerresheimer AG
• 13. Grand River Aseptic Manufacturing
• 14. Groninger & Co. GmbH
• 15. Jubilant HollisterStier CMO
• 16. MabPlex International Co. Ltd.
• 17. Novartis AG
• 18. OPTIMA Packaging Group GmbH
• 19. Pfizer Inc.
• 20. Piramal Pharma Solutions
• 21. Recipharm AB
• 22. Societal CDMO
• 23. Syngene International Ltd.
• 24. Syntegon Pharma Technology
• 25. Vetter Pharma International